Mingxin Pan
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 23
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver physiology and pathology 7
- Liver Disease and Transplantation 7
-
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 5
Mingxin Pan
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 415
- Hepatology 189
- Oncology 348
- Pulmonary and Respiratory Medicine 285
- Molecular Biology 559
Countries citing papers authored by Mingxin Pan
This map shows the geographic impact of Mingxin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxin Pan more than expected).
Fields of papers citing papers by Mingxin Pan
This network shows the impact of papers produced by Mingxin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxin Pan. The network helps show where Mingxin Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingxin Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 111 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 37 | |
| 12 | 2019 | 30 | |
| 13 | 2019 | 117 | |
| 14 | 2019 | 41 | |
| 15 | 2019 | 283 | |
| 16 | Marginatoxin induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway | 2017 | 1 |
| 17 | 2015 | 1 | |
| 18 | 2015 | 12 | |
| 19 | 2015 | 15 | |
| 20 | 2004 | 15 |
About Mingxin Pan
Mingxin Pan is a scholar working on Hepatology, Cancer Research, Surgery, Oncology and Pharmacology, having authored 72 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Organ Transplantation Techniques and Outcomes (8 papers), Liver physiology and pathology (7 papers), Liver Disease and Transplantation (7 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (415 citations), Hepatology (189 citations), Oncology (348 citations), Pulmonary and Respiratory Medicine (285 citations) and Molecular Biology (559 citations). Mingxin Pan has collaborated with scholars based in China and United States. Frequent co-authors include Yuan Cheng, Guolin He, Shibin Yang, Xueqing Yao, Weidong Li, Rui Li, Lijun Xu, Yanqing Ding, Rui Zhou and Hui Wang. Their work appears in journals such as World Journal of Gastroenterology, Scientific Reports, Journal of Gastrointestinal Surgery, Journal of Visualized Experiments and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.